These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29087982)
1. Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer. Yen TWF; Laud PW; Pezzin LE; McGinley EL; Wozniak E; Sparapani R; Nattinger AB Med Care; 2018 Jan; 56(1):78-84. PubMed ID: 29087982 [TBL] [Abstract][Full Text] [Related]
2. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Che Bakri NA; Kwasnicki RM; Khan N; Ghandour O; Lee A; Grant Y; Dawidziuk A; Darzi A; Ashrafian H; Leff DR Ann Surg; 2023 Apr; 277(4):572-580. PubMed ID: 35946806 [TBL] [Abstract][Full Text] [Related]
3. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709 [TBL] [Abstract][Full Text] [Related]
5. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer. Yen TW; Laud PW; Sparapani RA; Nattinger AB JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337 [TBL] [Abstract][Full Text] [Related]
6. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era. Mann JM; Wu X; Christos P; Nagar H Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423 [TBL] [Abstract][Full Text] [Related]
7. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Yen TW; Fan X; Sparapani R; Laud PW; Walker AP; Nattinger AB Ann Surg Oncol; 2009 Apr; 16(4):979-88. PubMed ID: 19194754 [TBL] [Abstract][Full Text] [Related]
8. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760 [TBL] [Abstract][Full Text] [Related]
9. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection. Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828 [TBL] [Abstract][Full Text] [Related]
10. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057 [TBL] [Abstract][Full Text] [Related]
11. Axillary treatment for operable primary breast cancer. Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708 [TBL] [Abstract][Full Text] [Related]
13. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174 [TBL] [Abstract][Full Text] [Related]
14. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients. Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019 [TBL] [Abstract][Full Text] [Related]
15. Arm lymphoedema after axillary surgery in women with invasive breast cancer. Sackey H; Magnuson A; Sandelin K; Liljegren G; Bergkvist L; Fülep Z; Celebioglu F; Frisell J Br J Surg; 2014 Mar; 101(4):390-7. PubMed ID: 24536010 [TBL] [Abstract][Full Text] [Related]
16. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180 [TBL] [Abstract][Full Text] [Related]
17. Comparison of lymphedema in patients with axillary lymph node dissections to those with sentinel lymph node biopsy followed by immediate and delayed ALND. Kuwajerwala NK; Feczko C; Dekhne N; Pettinga J; Lucia VC; Riutta J; Vicini F Am J Clin Oncol; 2013 Feb; 36(1):20-3. PubMed ID: 22157215 [TBL] [Abstract][Full Text] [Related]
18. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy? Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955 [TBL] [Abstract][Full Text] [Related]
19. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412 [TBL] [Abstract][Full Text] [Related]
20. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]